Ovid Therapeutics Inc - OVID Buxgalteriya kapitallashuvi

Ovid Rx (OVID) kompaniyasining rasmiy ramzlari

GURU.Markets platformasida Ovid Therapeutics Inc. (OVID) narxlar tarixi hozirda 0.21 darajasida. Ovid Therapeutics Inc. (OVID) o'z laboratoriyalarida energiyani tejash va chiqindilarni tozalash orqali atrof-muhitga bo'lgan ta'sirni minimallashtiradi. Biznes epilepsiyani davolash uchun noyob ferment preparatlarini ishlab chiqishga tayanadi va sodiq bemorlarning yopiq tarmog'ini shakllantiradi. Shu bilan birga, tibbiyotning gumanitar maqomi savdo mojarolarining ta'sirini istisno qilgani sababli, Amerika fanining rivojlanishi barqarorligicha qolmoqda.

OVID: Ovid Rx Balans kapitallashuvi 04.07.2022 - 29.10.2026

OVID (Ovid Rx): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- bozor narxi va tahlilchilarning maqsadli narxlari:
Birja grafigi Ovid Therapeutics Inc.|OVID - Tahlilchilar konsensus prognozi
- emitentning bozor qiymati haqida ma'lumotlar:
Bozor kapitallashuvi Ovid Therapeutics Inc|OVID - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi ko'rsatkichlari:
Bitta aksiya hisobiga xususiy kapital Ovid Therapeutics|OVID - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti ovidrx.com|OVID - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Ovid Therapeutics Inc.|OVID - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Ovid Therapeutics Inc.|OVID - Kompaniya qarzlari|Balans qiymatiga qarzlar Ovid Therapeutics Inc|OVID - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Ovid Therapeutics
Kompaniyaning dastlabki tahlili:OVID, Ovid Therapeutics
ovidrx.com seriyali mahsuloti

Ovid Therapeutics Inc. (OVID) rivojlanishi klinik bosqichlarning muvaffaqiyati va sheriklik to'lovlariga bog'liq bo'lib, bu balansdagi kapital hajmidagi o'zgarishlarga bevosita ta'sir ko'rsatadi. Sof aktivlardan majburiyatlar ayirib tashlangan summani ifodalovchi ushbu ko'rsatkich real moliyaviy barqarorlikni va biznesning tiklanish sur'atini belgilaydi. Ushbu ko'rsatkichning mahalliy pasayishi xatarlardan signal berishi mumkin, uning o'sishi esa kapitalizatsiyaning ishonchliligini tasdiqlaydi.

Raqobatchilar tahlili

Biznesning balans bahosi Biogen Idec BIIB|NBIX: Balans kapitallashuvi|Buxgalteriya kapitallashuvi RGC|Kompaniyaning balans qiymati Axsome Therapeutics, Inc.|Buxgalteriya kapitallashuvi ACAD (ACADIA Pharma)|Balans kapitallashuvi XENE|VKTX - Kompaniyaning xususiy kapitali|Supernus Pharmaceuticals - Kompaniyaning sof aktivlari|Balans kapitallashuvi catalystpharma.com CPRX|DNLI - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati HRMY (Harmony Biosciences Inc)|Biohaven Pharmaceutical (BHVN) - Kompaniyaning balans qiymati|Kompaniyaning xususiy kapitali Amylyx Corp (AMLX)|Kompaniyaning balans qiymati Trevi Therapeutics|Kompaniyaning xususiy kapitali praxismedicines.com PRAX|Kompaniyaning sof aktivlari AVXL (Anavex Life Sciences Corp.)|Kompaniyaning balans qiymati CBLL (CeriBell Inc)|Balans kapitallashuvi PRTA (prothena.com)|Biznesning balans bahosi Alector Inc. (ALEC)|Annexon, Inc. - Balans kapitallashuvi|OMER (Omeros Corporation) - Buxgalteriya kapitallashuvi|NGNE (Neurogene) - Kompaniyaning sof aktivlari|AC Immune S.A. - Kompaniyaning buxgalteriya qiymati|Kompaniyaning sof aktivlari VYGR|NMRA (Neumora Corp) - Jami sof aktivlar|Balans kapitallashuvi SCLX|TVGN (tevogen.com) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi ACOG (Alpha Cognition Inc.)|cogrx.com (CGTX) - Kompaniyaning xususiy kapitali|IKT - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati SAVA (Cassava Pharma)|ASRT: Balans kapitallashuvi|Coya Therapeutics (COYA) - Balans kapitallashuvi|Kompaniyaning balans qiymati VistaGen Therapeutics, Inc.|Acumen Pharmaceuticals Inc. - Sof aktivlar qiymati|Balans kapitallashuvi CRVO|ATHE - Kompaniyaning xususiy kapitali|Clene - Kompaniyaning sof aktivlari|Balans kapitallashuvi PepGen Inc PEPG|JUNS: Kompaniyaning sof aktivlari|Relmada Therapeutics Inc - Jami sof aktivlar|ANVS: Balans kapitallashuvi|GRCE - Biznesning balans bahosi|AIFF (Firefly Neuroscience, Inc) - Balans kapitallashuvi|Kompaniyaning sof aktivlari ANEW Medical, Inc. (KLTO)|Kompaniyaning balans qiymati NeuroSense Therapeutics (NRSN)|Biznesning balans bahosi Reviva Pharmaceuticals Holdings Inc.|MetaVia - Kompaniyaning sof aktivlari|Kompaniyaning buxgalteriya qiymati NRXS|Helius Medical Technologies Inc. - Balans kapitallashuvi|Biznesning balans bahosi Passage Bio, Inc. PASG|bionomics.com.au (NEUP) - Kompaniyaning balans qiymati|Buxgalteriya kapitallashuvi NERV|ATHA (Athira) - Balans kapitallashuvi|Kompaniyaning sof aktivlari Addex (ADXN)|Kompaniyaning sof aktivlari ALZN (Alzamend Neuro, Inc.)|Biznesning balans bahosi cyclerion.com|Kompaniyaning balans qiymati Protagenic Therapeutics, Inc. PTIX|Pasithea Therapeutics Corp (KTTA) - Kompaniyaning xususiy kapitali|CRGT: Kompaniyaning sof aktivlari|ATXI: Kompaniyaning balans qiymati|BCLI: Balans kapitallashuvi|CARA - Biznesning balans bahosi|CHRO (Chromocell Therapeutics Corp.) - Balans kapitallashuvi|Buxgalteriya kapitallashuvi ELYM (Eliem)|Kompaniyaning balans qiymati Intra-Cellular Therapies (ITCI)|Longboard - Buxgalteriya kapitallashuvi|Balans kapitallashuvi MRNS (Marinus Pharmaceuticals)|nkgenbiotech.com (NKGN) - Kompaniyaning xususiy kapitali|NRBO: Kompaniyaning sof aktivlari|SAGE - Balans kapitallashuvi|Neurotrope (SNPX) - Kompaniyaning balans qiymati|Trevena Inc - Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati Vigil Neuroscience Inc.|Kompaniyaning xususiy kapitali Anew Medical Inc. WENA|Kompaniyaning balans qiymati Cerevel Therapeutics, Inc. (CERE)